{"slideshow_credits": null, "snippet": "Shares in Regado Biopharmaceuticals, a drug maker and the only company to stage its market debut on Thursday, had risen more than 20 percent before Nasdaq halted trading in all its listed stocks.", "abstract": "Shares in Regado Biopharmaceuticals, a drug maker and the only company to stage its market debut on Thursday, had risen more than 20 percent before Nasdaq halted trading in all its listed stocks.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2013/08/22/nasdaqs-halt-pauses-a-good-day-for-a-newly-public-company/", "lead_paragraph": null, "headline": {"main": "Nasdaq's Halt Briefly Pauses a Good Day for a Newly Public Company", "kicker": "DealBook"}, "_id": "5220bd1c38f0d8740ac9b640", "word_count": "222", "multimedia": [], "pub_date": "2013-08-22T14:42:48Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "NASDAQ OMX Group Inc", "rank": "1"}, {"name": "subject", "value": "Initial Public Offerings", "rank": "1"}, {"name": "subject", "value": "Nasdaq Composite Index", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}